Investigation of triple-negative breast cancer risk alleles in an International African-enriched cohort
暂无分享,去创建一个
Melissa B. Davis | L. Newman | R. Kittles | B. Awuah | M. Davis | D. Chitale | C. Yates | P. Nikolinakos | S. Hoda | P. Ginter | E. Cheng | Yalei Chen | L. Petersen | E. Abebe | K. Ankomah | E. Osei-Bonsu | J. Oppong | E. Adjei | E. Jiagge | K. Gyan | A. Jibril | J. Bensenhaver | M. Bekele | I. Kyei | E. Proctor | Brittany D. Jenkins | I. Elhussin | F. Aitpillah | R. Martini | Jeffrey Hanover | Rozina B. Zeidan | M. Adinku | Saul David Nathansan | L. Jackson | Isra Elhussin
[1] Melissa B. Davis,et al. Oncologic Anthropology: An Interdisciplinary Approach to Understanding the Association Between Genetically Defined African Ancestry and Susceptibility for Triple Negative Breast Cancer , 2021, Current Breast Cancer Reports.
[2] P. Kubatka,et al. Breast Cancer in Young Women: Status Quo and Advanced Disease Management by a Predictive, Preventive, and Personalized Approach , 2019, Cancers.
[3] S. Merajver,et al. Hereditary Susceptibility for Triple Negative Breast Cancer Associated With Western Sub-Saharan African Ancestry: Results From an International Surgical Breast Cancer Collaborative. , 2019, Annals of surgery.
[4] A. Jemal,et al. Cancer statistics for African Americans, 2019 , 2019, CA: a cancer journal for clinicians.
[5] S. Weiss,et al. Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells. , 2019, Cell reports.
[6] R. Aneja,et al. The persisting puzzle of racial disparity in triple negative breast cancer: looking through a new lens. , 2019, Frontiers in bioscience.
[7] Abigail Silva,et al. Predictors of breast cancer mortality among white and black women in large United States cities: an ecologic study , 2019, Cancer Causes & Control.
[8] J. Corn,et al. The CUL5 ubiquitin ligase complex mediates resistance to CDK9 and MCL1 inhibitors in lung cancer cells , 2019, bioRxiv.
[9] L. Newman,et al. Triple-Negative Breast Cancer, Stem Cells, and African Ancestry. , 2017, The American journal of pathology.
[10] Chad J. Creighton,et al. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses , 2017, Neoplasia.
[11] J. Dutil,et al. Clinical Cancer Genetics Disparities among Latinos , 2017, Journal of Genetic Counseling.
[12] C. Shriver,et al. Contribution of germline mutations in cancer predisposition genes to tumor etiology in young women diagnosed with invasive breast cancer , 2017, Breast Cancer Research and Treatment.
[13] L. Newman,et al. Health Disparities and Triple-Negative Breast Cancer in African American Women: A Review , 2017, JAMA surgery.
[14] Eric S. Lander,et al. Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras , 2017, Cell.
[15] R. Wolff,et al. The Interaction between Genetic Ancestry and Breast Cancer Risk Factors among Hispanic Women: The Breast Cancer Health Disparities Study , 2016, Cancer Epidemiology, Biomarkers & Prevention.
[16] C. Rotimi,et al. The African diaspora: history, adaptation and health. , 2016, Current opinion in genetics & development.
[17] Lara E Sucheston-Campbell,et al. Trans-ethnic follow-up of breast cancer GWAS hits using the preferential linkage disequilibrium approach , 2016, Oncotarget.
[18] Christopher A Haiman,et al. Genetic variation in the insulin, insulin-like growth factor, growth hormone, and leptin pathways in relation to breast cancer in African-American women: the AMBER consortium , 2016, npj Breast Cancer.
[19] S. Fullerton,et al. Genomics is failing on diversity , 2016, Nature.
[20] Lara E Sucheston-Campbell,et al. Admixture Mapping of African–American Women in the AMBER Consortium Identifies New Loci for Breast Cancer and Estrogen-Receptor Subtypes , 2016, Front. Genet..
[21] Ernest Osei Bonsu,et al. Comparative Analysis of Breast Cancer Phenotypes in African American, White American, and West Versus East African patients: Correlation Between African Ancestry and Triple-Negative Breast Cancer , 2016, Annals of Surgical Oncology.
[22] S. Merajver,et al. Breast Cancer and African Ancestry: Lessons Learned at the 10-Year Anniversary of the Ghana-Michigan Research Partnership and International Breast Registry , 2016, Journal of global oncology.
[23] R. Foisner,et al. Nucleo-cytoplasmic shuttling of the endonuclease ankyrin repeats and LEM domain-containing protein 1 (Ankle1) is mediated by canonical nuclear export- and nuclear import signals , 2016, BMC Cell Biology.
[24] R. Foisner,et al. Nucleo-cytoplasmic shuttling of the endonuclease ankyrin repeats and LEM domain-containing protein 1 (Ankle1) is mediated by canonical nuclear export- and nuclear import signals , 2016, BMC Cell Biology.
[25] J. Mefford,et al. Mutational Landscape of Aggressive Prostate Tumors in African American Men. , 2016, Cancer research.
[26] L. Newman. Parsing the Etiology of Breast Cancer Disparities. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] Lara E Sucheston-Campbell,et al. Gene-based analysis of the fibroblast growth factor receptor signaling pathway in relation to breast cancer in African American women: the AMBER consortium , 2016, Breast Cancer Research and Treatment.
[28] Emily J. Girard,et al. Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells. , 2015, Cell reports.
[29] E. Howerth,et al. Distinct Transcript Isoforms of the Atypical Chemokine Receptor 1 (ACKR1) / Duffy Antigen Receptor for Chemokines (DARC) Gene Are Expressed in Lymphoblasts and Altered Isoform Levels Are Associated with Genetic Ancestry and the Duffy-Null Allele , 2015, PloS one.
[30] Christopher I. Li,et al. Racial Disparities in Breast Cancer Diagnosis and Treatment by Hormone Receptor and HER2 Status , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[31] Gabor T. Marth,et al. A global reference for human genetic variation , 2015, Nature.
[32] T. Akinyemiju,et al. Breast cancer survival in African-American women by hormone receptor subtypes , 2015, Breast Cancer Research and Treatment.
[33] Yang Zhang,et al. I-TASSER server: new development for protein structure and function predictions , 2015, Nucleic Acids Res..
[34] Kevin A. Henry,et al. Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State , 2015, Journal of the National Cancer Institute.
[35] L. Newman,et al. The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: Triple-Negative Breast Cancer , 2015, Annals of Surgical Oncology.
[36] P. Brown,et al. Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry. , 2014, The Lancet. Oncology.
[37] R. Kittles,et al. Association of Genetic Ancestry with Breast Cancer in Ethnically Diverse Women from Chicago , 2014, PLoS ONE.
[38] P. Blasio,et al. BRCA1 point mutations in premenopausal breast cancer patients from Central Sudan , 2014, Familial Cancer.
[39] P. Blasio,et al. BRCA1 point mutations in premenopausal breast cancer patients from Central Sudan , 2014, Familial Cancer.
[40] John M S Bartlett,et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. , 2014, Archives of pathology & laboratory medicine.
[41] Benjamin E. Gross,et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.
[42] C. Rotimi,et al. Genetic Susceptibility Loci for Subtypes of Breast Cancer in an African American Population , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[43] Clement Adebamowo,et al. A genome-wide association study of breast cancer in women of African ancestry , 2012, Human Genetics.
[44] Yang Zhang,et al. COFACTOR: an accurate comparative algorithm for structure-based protein function annotation , 2012, Nucleic Acids Res..
[45] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[46] Josef Gotzmann,et al. The endonuclease Ankle1 requires its LEM and GIY-YIG motifs for DNA cleavage in vivo , 2012, Journal of Cell Science.
[47] L. Newman,et al. Higher population‐based incidence rates of triple‐negative breast cancer among young African‐American women , 2011, Cancer.
[48] Caroline W. Kabaria,et al. The global distribution of the Duffy blood group , 2011, Nature communications.
[49] Christiana Kartsonaki,et al. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population , 2010, Nature Genetics.
[50] A. Whittemore,et al. Common variants at 19p13 are associated with susceptibility to ovarian cancer , 2010, Nature Genetics.
[51] Anthony Rhodes,et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. , 2010, Archives of pathology & laboratory medicine.
[52] A. Need,et al. Next generation disparities in human genomics: concerns and remedies. , 2009, Trends in genetics : TIG.
[53] L. Newman,et al. The Sisters Network: A National African American Breast Cancer Survivor Advocacy Organization. , 2009, Journal of oncology practice.
[54] Gabriel Silva,et al. An ancestry informative marker set for determining continental origin: validation and extension using human genome diversity panels , 2009, BMC Genetics.
[55] Gabriel Silva,et al. Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America , 2009, Human mutation.
[56] S. Tishkoff,et al. African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping. , 2008, Annual review of genomics and human genetics.
[57] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[58] Michael Peyton,et al. Synthetic lethal screen identification of chemosensitizer loci in cancer cells , 2007, Nature.
[59] L. Esserman,et al. Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. , 2005, JAMA.
[60] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[61] M. Stephens,et al. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. , 2003, Genetics.
[62] S. O’Brien,et al. Markers for mapping by admixture linkage disequilibrium in African American and Hispanic populations. , 2001, American journal of human genetics.
[63] C. Tournamille,et al. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy–negative individuals , 1995, Nature Genetics.
[64] F. B. Livingstone. The Duffy blood groups, vivax malaria, and malaria selection in human populations: a review. , 1984, Human biology.
[65] A. Jemal,et al. Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.
[66] Limin Peng,et al. Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer , 2016, Breast Cancer Research and Treatment.
[67] Anthony Rhodes,et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). , 2010, Archives of pathology & laboratory medicine.
[68] Yang Zhang,et al. I‐TASSER: Fully automated protein structure prediction in CASP8 , 2009, Proteins.
[69] C. Boring,et al. Cancer statistics for african americans , 1992, CA: a cancer journal for clinicians.
[70] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.